Cargando…
Growth Inhibitory and Pro-Apoptotic Effects of Hirsuteine in Chronic Myeloid Leukemia Cells through Targeting Sphingosine Kinase 1
Chronic myeloid leukemia (CML) is a slowly progressing hematopoietic cell disorder. Sphingosine kinase 1 (SPHK1) plays established roles in tumor initiation, progression, and chemotherapy resistance in a wide range of cancers, including leukemia. However, small-molecule inhibitors targeting SPHK1 in...
Autores principales: | Gao, Shan, Guo, Tingting, Luo, Shuyu, Zhang, Yan, Ren, Zehao, Lang, Xiaona, Hu, Gaoyong, Zuo, Duo, Jia, Wenqing, Kong, Dexin, Yu, Haiyang, Qiu, Yuling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622316/ https://www.ncbi.nlm.nih.gov/pubmed/35702821 http://dx.doi.org/10.4062/biomolther.2022.023 |
Ejemplares similares
-
Anticancer efficacy of hirsuteine against colorectal cancer by opposite modulation of wild-type and mutant p53
por: Zhang, Yan, et al.
Publicado: (2023) -
Inhibitory effect and mechanism of hirsuteine on NCI‑H1299 lung cancer cell lines
por: Yun, Xuelin, et al.
Publicado: (2023) -
Effects of hirsuteine on MDA-MB-453 breast cancer cell proliferation
por: Meng, Jie, et al.
Publicado: (2022) -
Tissue Distribution of Hirsutine and Hirsuteine in Mice by Ultrahigh-Performance Liquid Chromatography-Mass Spectrometry
por: Zhou, Quan, et al.
Publicado: (2020) -
Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia
por: Zhou, Cheng, et al.
Publicado: (2022)